Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 6, Issue 5, Pages e1761-e1761
Publisher
Springer Nature
Online
2015-05-14
DOI
10.1038/cddis.2015.129
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracellular adenosine metabolism in immune cells in melanoma
- (2014) Viktor Umansky et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Extracellular ATP drives systemic inflammation, tissue damage and mortality
- (2014) A Cauwels et al. Cell Death & Disease
- The Translocation of Nuclear Molecules During Inflammation and Cell Death
- (2013) David S. Pisetsky ANTIOXIDANTS & REDOX SIGNALING
- Development of a novel methodology for cryopreservation of melanoma cells applied to CSF470 therapeutic vaccine
- (2013) Ivana J. Tapia et al. CRYOBIOLOGY
- The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
- (2013) James M. Murphy et al. IMMUNITY
- Many faces of DAMPs in cancer therapy
- (2013) O Krysko et al. Cell Death & Disease
- Dendritic Cells in the Cancer Microenvironment
- (2013) Yang Ma et al. Journal of Cancer
- An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
- (2013) E. B. Golden et al. Cancer Immunology Research
- The Intrinsic Apoptosis Pathways as a Target in Anticancer Therapy
- (2012) Verena Jendrossek CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Old and new facts about hyperthermia-induced modulations of the immune system
- (2012) Benjamin Frey et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Autophagy and ionizing radiation in tumors: The “survive or not survive” dilemma
- (2012) Silvia Palumbo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sensitization to the mitochondrial pathway of apoptosis augments melanoma tumor cell responses to conventional chemotherapeutic regimens
- (2012) R A Anvekar et al. Cell Death & Disease
- OncoImmunology: a new journal at the frontier between oncology and immunology
- (2012) Laurence Zitvogel et al. OncoImmunology
- Selected anti-tumor vaccines merit a place in multimodal tumor therapies
- (2012) Eva-Maria Weiss et al. Frontiers in Oncology
- How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity?
- (2012) Yvonne Rubner et al. Frontiers in Oncology
- High-Mobility Group Box 1 Release and Redox Regulation Accompany Regeneration and Remodeling of Skeletal Muscle
- (2011) Michela Vezzoli et al. ANTIOXIDANTS & REDOX SIGNALING
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
- (2011) J. Fucikova et al. CANCER RESEARCH
- The Evolving Role of Radiation Therapy in the Management of Malignant Melanoma
- (2011) Niloufer Khan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
- (2011) Camilo E. Fadul et al. JOURNAL OF IMMUNOTHERAPY
- Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition
- (2011) P. M. Krawczyk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages
- (2011) Petra Schildkopf et al. RADIOTHERAPY AND ONCOLOGY
- Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
- (2010) L. Aymeric et al. CANCER RESEARCH
- High-mobility group box 1 (HMGB1) as a master regulator of innate immunity
- (2010) Alessandra Castiglioni et al. CELL AND TISSUE RESEARCH
- zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFα mediated by the PKC–MAPKs–AP-1 pathway
- (2010) Y-T Wu et al. CELL DEATH AND DIFFERENTIATION
- Necroptosis as an alternative form of programmed cell death
- (2010) Dana E Christofferson et al. CURRENT OPINION IN CELL BIOLOGY
- Molecular mechanisms of necroptosis: an ordered cellular explosion
- (2010) Peter Vandenabeele et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Extracellular BCL2 Proteins Are Danger-Associated Molecular Patterns That Reduce Tissue Damage in Murine Models of Ischemia-Reperfusion Injury
- (2010) Akiko Iwata et al. PLoS One
- Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features
- (2009) T Vanden Berghe et al. CELL DEATH AND DIFFERENTIATION
- Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor
- (2009) L. Moretti et al. MOLECULAR CANCER THERAPEUTICS
- Clearance deficiency—A potential link between infections and autoimmunity
- (2008) C. Schulze et al. AUTOIMMUNITY REVIEWS
- The anticancer immune response: indispensable for therapeutic success?
- (2008) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
- Intratumoral Dendritic Cells and Chemoradiation for the Treatment of Murine Squamous Cell Carcinoma
- (2008) Jeffrey S. Moyer et al. JOURNAL OF IMMUNOTHERAPY
- Mechanisms Involved in Radiation Enhancement of Intratumoral Dendritic Cell Therapy
- (2008) Seagal Teitz-Tennenbaum et al. JOURNAL OF IMMUNOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started